<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: chemical compound</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Study provides potential explanation for mechanisms of associative memory</title>
   	 <description>Researchers from the University of Bristol have discovered that a chemical compound in the brain can weaken the synaptic connections between neurons in a region of the brain important for the formation of long-term memories. The findings, published today in the Journal of Neuroscience, may also provide a potential explanation for the loss of memory associated with Alzheimer's.</description>
	  <link>http://medicalxpress.com/news/2011-12-potential-explanation-mechanisms-associative-memory.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Tue, 13 Dec 2011 17:00:01 EST</pubDate>
	 <guid isPermaLink="false">news243004672</guid>
	 
</item>
<item>
     <title>Everest expedition suggests nitric oxide benefits for intensive care patients</title>
   	 <description>The latest results from an expedition to Mount Everest that looked at the body's response to low oxygen levels suggest that drugs or procedures that promote the body's production of a chemical compound called nitric oxide (NO) could improve the recovery of critically ill patients in intensive care.</description>
	  <link>http://medicalxpress.com/news/2011-10-everest-nitric-oxide-benefits-intensive.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 06 Oct 2011 07:19:07 EST</pubDate>
	 <guid isPermaLink="false">news237104331</guid>
	 
</item>
<item>
     <title>Scientists uncover new ways to stimulate pancreatic beta cell growth</title>
   	 <description>One of the holy grails in diabetes research is to discover molecules that stimulate beta cell growth and to find drugs that target these molecules. Now, JDRF-funded researchers in collaboration with the pharmaceutical company Hoffmann-La Roche, have done both, discovering not only a protein that regulates beta cell growth, but also a chemical compound that stimulates it. The work appears in the September 7 issue of Cell Metabolism.</description>
	  <link>http://medicalxpress.com/news/2011-09-scientists-uncover-ways-pancreatic-beta.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 06 Sep 2011 14:48:20 EST</pubDate>
	 <guid isPermaLink="false">news234539287</guid>
	 
</item>
<item>
     <title>Undiagnosed trimethylaminuria may explain many cases of personal malodor</title>
   	 <description>Scientists from the Monell Center report that approximately one third of patients with unexplained body malodor production test positive for the metabolic disorder trimethylaminuria (TMAU). A definitive diagnosis offers relief to these individuals, as symptoms of TMAU can hinder social and workplace interactions and cause psychological distress. But once the disease is identified, these debilitating symptoms can be ameliorated using changes in diet and other approaches.</description>
	  <link>http://medicalxpress.com/news/2011-08-undiagnosed-trimethylaminuria-cases-personal-malodor.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 31 Aug 2011 11:37:04 EST</pubDate>
	 <guid isPermaLink="false">news234009403</guid>
	 
</item>
<item>
     <title>New compound may accelerate bone healing, prevent osteoporosis</title>
   	 <description>An Indiana University scientist studying human bone growth has received a $2.6 million grant from the U.S. Department of Defense to study a chemical compound with potential to fight osteoporosis and accelerate broken bone healing.</description>
	  <link>http://medicalxpress.com/news/2011-08-compound-bone-osteoporosis.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 17 Aug 2011 15:44:48 EST</pubDate>
	 <guid isPermaLink="false">news232814657</guid>
	 
</item>
<item>
     <title>Therapy appears to reduce rate of chemotherapy-induced early menopause for women with breast cancer</title>
   	 <description>Temporarily suppressing ovarian function with use of the hormone analogue triptorelin reduced the occurrence of early menopause induced by chemotherapy among women with breast cancer, according to a study in the July 20 issue of JAMA.</description>
	  <link>http://medicalxpress.com/news/2011-07-therapy-chemotherapy-induced-early-menopause-women.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 19 Jul 2011 16:51:27 EST</pubDate>
	 <guid isPermaLink="false">news230313077</guid>
	 
</item>
<item>
     <title>Breakthrough in the search for new treatments for multiple sclerosis</title>
   	 <description>Scientists at The University of Nottingham have discovered a molecular mechanism which could bring about the development of new treatments for Multiple Sclerosis (MS) -- a chronic inflammatory disease of the central nervous system.</description>
	  <link>http://medicalxpress.com/news/2011-06-breakthrough-treatments-multiple-sclerosis.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 21 Jun 2011 09:27:54 EST</pubDate>
	 <guid isPermaLink="false">news227867260</guid>
	 
</item>


</channel>
</rss>
